SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001048477-20-000016
Filing Date
2020-05-01
Accepted
2020-05-01 13:54:26
Documents
89
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q bmrn-20200331.htm   iXBRL 10-Q 2425525
2 EX-31.1 exhibit311-31mar20x10q.htm EX-31.1 10225
3 EX-31.2 exhibit312-31mar20x10q.htm EX-31.2 10705
4 EX-32.1 exhibit321-31mar20x10q.htm EX-32.1 6539
  Complete submission text file 0001048477-20-000016.txt   10856228

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20200331.xsd EX-101.SCH 63431
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20200331_cal.xml EX-101.CAL 113923
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20200331_def.xml EX-101.DEF 331397
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20200331_lab.xml EX-101.LAB 724012
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20200331_pre.xml EX-101.PRE 491486
12 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20200331_htm.xml XML 2430778
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26727 | Film No.: 20839944
SIC: 2834 Pharmaceutical Preparations